Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$24,851,192
+$23,635,374 QoQ
Shares Held
32,164
+1577.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 98.74082825519214.ToString("F0")% Shared 0.ToString("F0")% None 1.2591717448078596.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. REGN ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
32,164 $24,851,192

All Filings in REGN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,851,192 32,164
2025-03-31 $1,215,818 1,917
2024-12-31 $665,316 934
2024-09-30 $21,561,983 20,511
2024-06-30 $9,987,938 9,503
2024-03-31 $1,925,942 2,001
2023-12-31 $1,919,941 2,186
2023-09-30 $2,194,011 2,666
2023-06-30 $12,181,408 16,953
2023-03-31 $24,475,084 29,787
2022-12-31 $13,135,446 18,206
2022-09-30 $2,916,675 4,234
2022-06-30 $1,849,054 3,128
2022-03-31 $5,819,235 8,332
2021-12-31 $11,202,533 17,739
2021-09-30 $7,177,434 11,860
2021-06-30 $13,954,563 24,984
2021-03-31 $12,296,908 25,990
2020-12-31 $4,011,262 8,303
2020-09-30 $4,006,905 7,158
2020-06-30 $3,023,455 4,848
2020-03-31 $1,918,979 3,930